The share price of Haemonetics Corporation (HAE) now
What analysts predict: $106.14
52-week High/Low: $95.26 / $72.26
50/200 Day Moving Average:
$87.91 / $85.55
This figure corresponds to the Average Price over the previous 50/200 days.
For Haemonetics stocks, the 50-day moving average is the resistance level today.
For Haemonetics stocks, the 200-day moving average is the resistance level today.
Are you interested in Haemonetics Corporation stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the Haemonetics
stock price in 2023, 2024, 2025, 2026, 2027.
How much will one Haemonetics share be worth in
2023 - 2027?
When should I take profit in Haemonetics stock?
When should I record a loss on Haemonetics stock?
What are analysts' forecasts for Haemonetics stock?
What is the future of Haemonetics stock?
We forecast Haemonetics stock performance using neural networks based on historical data on Haemonetics stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Haemonetics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2023, 2024, 2025, 2026 and 2027)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Haemonetics shares. This happens once a day.
Historical and forecast chart of Haemonetics stock
The chart below shows the historical price of Haemonetics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Haemonetics stock price can be found in the table below.
Long-term forecasts by years.
Haemonetics Corporation is a medical company offering hematology products and solutions. It operates through three segments: Plasma, Blood Center and Hospital. The company offers automated plasma collection devices, related disposable products and software, including NexSys PCS and PCS2 plasmapheresis equipment, as well as related disposable and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations and supply chain; and the NexLynk DMS Donor Management System.
Trending Themes in the Healthcare Sector
Haemonetics daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Dec 04
86.80
86.24
87.45
1.40
Dec 05
86.17
85.17
86.69
1.79
Dec 06
86.84
85.20
88.38
3.72
Dec 07
85.23
83.57
86.42
3.40
Dec 08
85.33
83.69
86.27
3.07
Dec 09
85.67
83.69
86.30
3.12
Dec 10
86.87
85.20
88.60
3.99
Dec 11
86.82
85.15
87.50
2.75
Dec 12
84.73
83.45
85.61
2.59
Dec 13
83.74
82.24
85.49
3.96
Dec 14
82.65
82.08
83.20
1.37
Dec 15
81.55
80.77
83.18
2.99
Dec 16
82.40
81.75
82.90
1.40
Dec 17
81.71
80.00
83.34
4.18
Dec 18
84.03
82.86
85.93
3.71
Dec 19
83.40
82.04
84.24
2.68
Dec 20
83.37
81.65
83.88
2.72
Dec 21
84.19
82.90
85.54
3.18
Dec 22
82.92
81.05
84.01
3.65
Dec 23
80.88
80.32
81.58
1.58
Dec 24
81.93
80.22
83.46
4.03
Dec 25
82.32
80.64
83.89
4.03
Dec 26
82.08
81.31
82.98
2.05
Dec 27
83.43
81.91
84.96
3.72
Dec 28
83.29
81.60
84.50
3.55
Dec 29
84.23
83.72
85.35
1.95
Dec 30
82.54
82.07
84.27
2.68
Dec 31
83.07
82.06
84.49
2.97
Jan 01
81.29
79.90
82.66
3.45
Jan 02
82.37
81.13
82.90
2.18
Haemonetics Daily Price Targets
Haemonetics Stock Forecast 12-04-2023.
Forecast target price for 12-04-2023: $86.80. Positive dynamics for Haemonetics shares will prevail with possible volatility of 1.382%. Pessimistic target level: 86.24 Optimistic target level: 87.45
Haemonetics Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $86.17. Negative dynamics for Haemonetics shares will prevail with possible volatility of 1.758%. Pessimistic target level: 85.17 Optimistic target level: 86.69
Haemonetics Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $86.84. Positive dynamics for Haemonetics shares will prevail with possible volatility of 3.590%. Pessimistic target level: 85.20 Optimistic target level: 88.38
Haemonetics Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $85.23. Negative dynamics for Haemonetics shares will prevail with possible volatility of 3.289%. Pessimistic target level: 83.57 Optimistic target level: 86.42
Haemonetics Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $85.33. Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.983%. Pessimistic target level: 83.69 Optimistic target level: 86.27
Haemonetics Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $85.67. Positive dynamics for Haemonetics shares will prevail with possible volatility of 3.023%. Pessimistic target level: 83.69 Optimistic target level: 86.30
Market capitalization of the Haemonetics Corporation is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of HAE shares in the company outstanding by the market price of one share.
EBITDA:
288 618 000 $
EBITDA of Haemonetics is earnings before interest, income tax and depreciation of assets.
PE Ratio:
32.91
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
2.151
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
0.0319
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
2.49
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
-0.25
Quarterly Revenue Growth YOY:
0.07
Trailing PE:
32.91
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
25.45
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
4.333
Enterprise Value (EV) /Revenue
EV To EBITDA:
20.65
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
50742000
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website